- Home
- FLNA vs KZIA Comparison
FLNA vs KZIA Comparison
Compare FLNA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.72
HOLD
Current Price
$9.10
Company Overview
Basic Information| Metric | FLNA | KZIA |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1M | 93.2M |
| IPO Year | N/A | 2002 |
Fundamental Metrics
Financial Performance| Metric | FLNA | KZIA |
|---|---|---|
| Price | $1.72 | $9.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | ★ 342.8K | 135.1K |
| Earning Date | 05-13-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $0.72 |
| 52 Week High | $2.03 | $17.40 |
Technical Indicators
Market Signals| Indicator | FLNA | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 62.90 |
| Support Level | $1.64 | $5.64 |
| Resistance Level | $1.78 | $10.49 |
| Average True Range (ATR) | 0.09 | 0.78 |
| MACD | -0.00 | 0.18 |
| Stochastic Oscillator | 35.71 | 76.36 |
Price Performance
Historical Comparison FLNA
KZIA
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.